|
TMEM109 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.129600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.671640E-02 |
| Normal-vs-Stage2 |
2.474200E-01 |
| Normal-vs-Stage3 |
3.443600E-01 |
| Normal-vs-Stage4 |
4.113000E-01 |
| Stage1-vs-Stage2 |
3.562700E-03 |
| Stage1-vs-Stage3 |
1.079830E-03 |
| Stage1-vs-Stage4 |
4.644600E-03 |
| Stage2-vs-Stage3 |
6.376400E-01 |
| Stage2-vs-Stage4 |
6.136800E-01 |
| Stage3-vs-Stage4 |
9.508800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.711200E-01 |
| Normal-vs-AfricanAmerican |
9.425800E-01 |
| Normal-vs-Asian |
7.481000E-01 |
| Caucasian-vs-AfricanAmerican |
7.048600E-01 |
| Caucasian-vs-Asian |
5.619400E-01 |
| AfricanAmerican-vs-Asian |
7.341800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.100600E-01 |
| Normal-vs-Female |
3.476400E-01 |
| Male-vs-Female |
4.543200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.215800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.917800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.195400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.889600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.724000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.710000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.981800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.552200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.793800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.148800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.216010E-04 |
| Normal-vs-Grade 2 |
3.044400E-02 |
| Normal-vs-Grade 3 |
6.131800E-01 |
| Normal-vs-Grade 4 |
9.016100E-02 |
| Grade 1-vs-Grade 2 |
3.351600E-02 |
| Grade 1-vs-Grade 3 |
1.555730E-03 |
| Grade 1-vs-Grade 4 |
1.984660E-04 |
| Grade 2-vs-Grade 3 |
3.261700E-03 |
| Grade 2-vs-Grade 4 |
4.836400E-04 |
| Grade 3-vs-Grade 4 |
1.750180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.601700E-03 |
| Normal-vs-ccB subtype |
5.464200E-02 |
| ccA subtype-vs-ccB subtype |
1.69949999961894E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.764800E-01 |
| Normal-vs-N1 |
9.194600E-01 |
| N0-vs-N1 |
9.476000E-01 |
|
|
